InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
53%
T+90 mean return
-0.4%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kono Ann, Director. Officer active across 3 companies, notably Sabra Health Care REIT, Inc.. Cumulatively, 25 disclosures have been logged. Activity tracked since 28 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations25 total
1,913 shares0Common StockSEC:0001437749-25-017493:0
843 shares0Common StockSEC:0001976617-25-000038:0
737 shares0Common StockSEC:0001862128-24-000046:0
793 shares0Common StockSEC:0001976617-24-000081:0
9,480 shares0Common StockSEC:0001976617-24-000059:0
719 shares0Common StockSEC:0001976617-24-000045:0
741 shares0Common StockSEC:0001862128-24-000020:0
688 shares0Common StockSEC:0001976617-23-000054:0
783 shares0Common StockSEC:0001862128-23-000048:0
11,382 shares0Common StockSEC:0001976617-23-000033:0
554 shares0Common StockSEC:0001976617-23-000019:0
512 shares0Common StockSEC:0001862128-23-000030:0
460 shares0Common StockSEC:0001862128-22-000105:0
389 shares0Common StockSEC:0001862128-22-000083:0
8,751 shares0Common StockSEC:0001862128-22-000063:0
224 shares0Common StockSEC:0001862128-22-000049:0
228 shares0Common StockSEC:0001862128-22-000025:0
232 shares0Common StockSEC:0001862128-21-000099
232 shares0Common StockSEC:0001862128-21-000099:0
184 shares0Common StockSEC:0001862128-21-000073:0
184 shares0Common StockSEC:0001862128-21-000073
6,438 shares0Common StockSEC:0001862128-21-000046
6,438 shares0Common StockSEC:0001862128-21-000046:0
57 shares0Common StockSEC:0001862128-21-000026
57 shares0Common StockSEC:0001862128-21-000026:0
25 of 25 declarations
About Kono Ann
Ann Kono is a Board Member at Sabra Health Care REIT, Inc. She contributes to the governance of the company, bringing her expertise in the healthcare sector. Her role is essential in guiding strategic decisions and ensuring the development of innovative solutions.
